查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2112253

醫藥契約製造和研發服務市場規模、佔有率和趨勢分析報告：按服務、地區和細分市場分類的預測（2026-2033 年）

Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends Analysis Report By Service, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

醫藥契約製造與研發服務市場概述

全球醫藥契約製造和研發服務市場預計到 2025 年將達到 2,831 億美元，到 2026 年將成長到 3038 億美元，到 2033 年將擴大到 4,721 億美元，2026 年至 2033 年的複合年成長率為 6.5%。

亞太地區是市場的主要驅動力，預計到 2025 年將佔據 42.3% 的最大市場佔有率。由於醫藥和生物技術外包的增加、生物製藥、生物契約製造藥和專科藥物研發活動的活性化、對經濟高效且靈活的生產方式的需求不斷成長、臨床試驗項目不斷擴展，以及對先進製造技術和一體化 CDMO/CRO 能力的投資增加，醫藥合約生產和研究服務行業預計將在預測期內成長。

此外，縮短研發週期、遵守複雜的監管要求以及在無需大量資本投入的情況下利用專業技術的能力等需求，進一步推動了市場成長。藥物發現、開發和商業化生產等各環節日益注重端到端外包，也增強了對契約製造和研發服務供應商的需求。

藥品研發和生產的外包趨勢日益成長，並持續成長要素。製藥和生物技術公司擴大與合約服務供應商合作，以降低基礎設施成本、提高營運柔軟性並加快產品開發進度。隨著生物製藥、細胞和基因療法、高效化合物以及個人化醫療變得日益複雜，對專業化生產和研發能力的需求也進一步增加。合約組織提供的一體化服務模式使發起公司能夠透過單一合作夥伴管理研發和商業化，同時提高營運效率並確保合規性。

主要服務供應商不斷擴大的生產能力和專業技術正在進一步推動市場成長。各公司持續投資於先進的生產技術和高附加價值製造基礎設施，以滿足日益成長的外包需求。例如，2024年11月，龍沙公司宣布將在其位於瑞士維斯普的工廠增設兩套1200公升的生產車間，以擴大其生物偶聯能力，滿足對複雜治療藥物日益成長的需求。這項投資預計將增強先進藥物的商業化生產能力，並提升其為全球製藥和生物技術公司提供的整合開發和生產服務。另一方面，嚴格的監管合規要求、先進生產設施的大量資本投資以及外包合約的價格壓力正在限制市場成長。預計未來幾年，對生物製藥、特種治療藥物和整合開發服務的需求不斷成長，以及新興市場製藥外包業務的擴張，將為契約製造和研發服務供應商帶來巨大的商機。總體而言，外包趨勢的日益成長、藥物開發平臺的擴展以及對專業研發和生產能力的持續投資，預計將支持醫藥契約製造和研究服務市場的長期成長。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：醫藥契約製造與研發服務市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技情勢
  • 定價模式分析
  • 關稅影響分析
  • 市場分析工具

第4章：醫藥契約製造與研發服務市場：按服務類型分類的估算與趨勢分析

  • 醫藥契約製造與研發服務市場：按服務類型分類的趨勢分析
  • 醫藥契約製造與研發服務市場：按服務類型分類的估算與預測，2021-2033年
  • 製造業
    • API/ 原料藥
    • 先進的藥物遞送製劑
    • 包裝
    • 精製劑
  • 調查
    • 腫瘤學
    • 疫苗
    • 發炎/免疫學
    • 循環系統
    • 神經科學
    • 其他

第5章：醫藥契約製造與研發服務市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • UAE
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第6章 競爭情勢

  • 主要公司分類
    • Market Leaders
    • Emerging Players
  • 2025年市佔率及估值分析（熱圖分析）
  • 公司簡介
    • Catalent, Inc.（Novo Holdings A/S）
    • PPD（Thermo Fisher Scientific Inc.）
    • AbbVie Inc.
    • Advent International, LP
    • Grifols
    • Dalton Pharma Services
    • Lonza
    • Boehringer Ingelheim International GmbH
Product Code: GVR-1-68038-924-1

Pharmaceutical Contract Manufacturing And Research Services Market Summary

The global pharmaceutical contract manufacturing and research services market size was valued at USD 283.1 billion in 2025 and is projected to grow from USD 303.8 billion in 2026 to USD 472.1 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest share of 42.3% in 2025. The pharmaceutical contract manufacturing and research services industry is anticipated to grow over the forecast period owing to increasing pharmaceutical and biotechnology outsourcing, rising research and development activities for biologics, biosimilars, and specialty drugs, growing demand for cost-efficient and flexible manufacturing, expanding clinical trial pipeline, and increasing investments in advanced manufacturing technologies and integrated CDMO and CRO capabilities.

The market growth is further supported by the need to reduce development timelines, manage complex regulatory requirements, and access specialized technical expertise without large capital investments. The growing focus on end-to-end outsourcing across drug discovery, development, and commercial manufacturing is strengthening demand for contract manufacturing and research service providers.

The increasing outsourcing of pharmaceutical development and manufacturing remains one of the primary growth drivers for the market. Pharmaceutical and biotechnology companies are increasingly partnering with contract service providers to reduce infrastructure costs, improve operational flexibility, and accelerate product development timelines. The growing complexity of biologics, cell and gene therapies, highly potent compounds, and personalized medicines has further increased the need for specialized manufacturing and research capabilities. The integrated service model offered by contract organizations enables sponsors to manage development and commercialization through a single partner while maintaining regulatory compliance and improving operational efficiency.

The expansion of manufacturing capacity and specialized capabilities across leading service providers is further supporting market growth. Companies continue to invest in advanced production technologies and high-value manufacturing infrastructure to address increasing outsourcing demand. For instance, in November 2024, Lonza announced the expansion of its bioconjugation capabilities at its Visp, Switzerland, facility by adding two 1,200 L manufacturing suites to support growing demand for complex therapeutics. The investment is expected to strengthen commercial manufacturing capacity for advanced pharmaceutical products and enhance integrated development and manufacturing services offered to global pharmaceutical and biotechnology companies. Market growth is moderated by stringent regulatory compliance requirements, high capital investment for advanced manufacturing facilities, and pricing pressure across outsourcing contracts. The increasing demand for biologics, specialty therapeutics, integrated development services, and the expansion of pharmaceutical outsourcing across emerging markets are expected to create significant opportunities for contract manufacturing and research service providers over the coming years. Overall, the increasing preference for outsourcing, expanding drug development pipelines, and continuous investments in specialized research and manufacturing capabilities are expected to support the long-term growth of the pharmaceutical contract manufacturing and research services market.

Global Pharmaceutical Contract Manufacturing And Research Services Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical contract manufacturing and research services market report based on service and region:

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Manufacturing
    • API/Bulk Drugs
    • Advanced Drug Delivery Formulations
    • Packaging
    • Finished Dose Formulations
    • Solid
    • Liquid
    • Semi-solid Formulations
  • Research
    • Oncology
    • Vaccines
    • Inflammation & Immunology
    • Cardiology
    • Neuroscience
    • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Contract Manufacturing And Research Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Pharmaceutical Contract Manufacturing And Research Services Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Contract Manufacturing And Research Services Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Contract Manufacturing And Research Services Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Contract Manufacturing And Research Services Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 4.4. Manufacturing
    • 4.4.1. Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. API/Bulk Drugs
      • 4.4.2.1. API/Bulk Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Advanced Drug Delivery Formulations
      • 4.4.3.1. Advanced Drug Delivery Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Packaging
      • 4.4.4.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Finished Dose Formulations
      • 4.4.5.1. Finished Dose Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.5.2. Solid
        • 4.4.5.2.1. Solid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.5.3. Liquid
        • 4.4.5.3.1. Liquid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.5.4. Semi-solid Formulations
        • 4.4.5.4.1. Semi-solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Research
    • 4.5.1. Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Oncology
      • 4.5.2.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Vaccines
      • 4.5.3.1. Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Inflammation & Immunology
      • 4.5.4.1. Inflammation & Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Cardiology
      • 4.5.5.1. Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Neuroscience
      • 4.5.6.1. Neuroscience Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pharmaceutical Contract Manufacturing And Research Services Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2025 & 2033
  • 5.3. North America
    • 5.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. U.S
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Europe
    • 5.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. UK
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Germany
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. France
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Italy
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.6. Spain
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.7. Denmark
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.8. Sweden
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Competitive Scenario
      • 5.4.8.3. Regulatory Framework
      • 5.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.9. Norway
      • 5.4.9.1. Key Country Dynamics
      • 5.4.9.2. Competitive Scenario
      • 5.4.9.3. Regulatory Framework
      • 5.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Japan
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. China
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.4. India
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Competitive Scenario
      • 5.5.4.3. Regulatory Framework
      • 5.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.5. Australia
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Competitive Scenario
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.6. Thailand
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Competitive Scenario
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.7. South Korea
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Competitive Scenario
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Latin America
    • 5.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Brazil
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. MEA
    • 5.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Competitive Scenario
      • 5.7.2.3. Regulatory Framework
      • 5.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Competitive Scenario
      • 5.7.3.3. Regulatory Framework
      • 5.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.4. Saudi Arabia
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Competitive Scenario
      • 5.7.4.3. Regulatory Framework
      • 5.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.5. Kuwait
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Competitive Scenario
      • 5.7.5.3. Regulatory Framework
      • 5.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.6. Qatar
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Competitive Scenario
      • 5.7.6.3. Regulatory Framework
      • 5.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.7.7. Oman
      • 5.7.7.1. Key Country Dynamics
      • 5.7.7.2. Competitive Scenario
      • 5.7.7.3. Regulatory Framework
      • 5.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Key Participant Categorization
    • 6.1.1. Market Leaders
    • 6.1.2. Emerging Players
  • 6.2. Market Share/Assessment Analysis, 2025 (Heat Map Analysis)
  • 6.3. Company Profiles
    • 6.3.1. Catalent, Inc. (Novo Holdings A/S)
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Service Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. PPD (Thermo Fisher Scientific Inc.)
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Service Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. AbbVie Inc.
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Service Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Advent International, L.P.
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Service Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Grifols
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Service Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Dalton Pharma Services
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Service Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Lonza
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Service Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Boehringer Ingelheim International GmbH
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Service Benchmarking
      • 6.3.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Region, 2021 - 2033 (USD Million)
  • Table 5 Global Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 6 North America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 8 U.S Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million)
  • Table 9 Canada Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 10 Mexico Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 Europe Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 12 Europe Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 13 UK Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million)
  • Table 14 Germany Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 15 France Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service Type, 2021 - 2033 (USD Million)
  • Table 16 Italy Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 17 Spain Pharmaceutical Contract Manufacturing And Research ServicesMarket Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 Denmark Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 19 Sweden Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 20 Norway Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 21 Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 22 Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 23 Japan Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24 China Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 25 India Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 26 Thailand Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 27 South Korea Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Australia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 29 Latin America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 30 Latin America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 31 Brazil Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 32 Argentina Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 33 Middle East & Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 34 Middle East & Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 35 South Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 36 Saudi Arabia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 UAE Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 38 Kuwait Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39 Oman Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 40 Qatar Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Pharmaceutical Contract Manufacturing And Research Services Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Contract Manufacturing And Research Services Market: Service outlook and key takeaways (USD Million)
  • Fig. 20 Pharmaceutical Contract Manufacturing And Research Services Market: Service movement analysis
  • Fig. 21 Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 API/Bulk Drugs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Advanced Drug Delivery Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Finished Dose Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Solid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Liquid Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Semi-solid Formulations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Research Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Vaccines Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Inflammation & Immunology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Cardiology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Neuroscience Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 North America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Canada Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Mexico Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Europe Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 UK Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Germany Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 France Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Italy Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Spain Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Sweden Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Norway Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Asia Pacific Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Japan Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 China Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 India Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Thailand Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 South Korea Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Australia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Middle East & Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 South Africa Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Saudi Arabia Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 UAE Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Oman Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Qatar Pharmaceutical Contract Manufacturing And Research Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)